Genmab — Oktober 2018
-
@livermore : no worries !
-
Genmab Announces Positive Topline Results in Phase III CASSIOPEIA Study of Daratumumab in Front Line Multiple Myeloma
-
CASSIOPEIA FØR MAIA, BUT WE TAKE IT ALL
-
Fint nok primary endpoint. Det er selvfølgelig nået med statistisk sikkerhed, men er resultatet så overbevisende at der vil komme et skift i behandlingerne ? Jeg hæfter mig ved at forsøget fortsætter med en ny randomisering hvor der vil blive givet Dara og alternativt ingen behandling. Det ville man nok ikke have gjort hvis Dara havde været totalt overbevisende ?
-
og her den danske version og god morgen https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=500017013&sourcecode=ddk
-
God motgen

-
*morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind